Fact CheckerSign in

NCT07228533Not yet recruiting

CesiKids Trial: Enhancing Psychological Resilience in Adolescents With Cancer

Evaluation of the Effectiveness of a Nursing-Based Co-Design Intervention Program (CesiKids) to Enhance Psychological Resilience in Hospitalized Adolescents Diagnosed With Cancer: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 14 Nov 2025

Brief summary (registry, in English)

This study will develop and evaluate a mobile-based co-design intervention (CesiKids) to enhance psychosocial resilience in hospitalized adolescents aged 12-18 diagnosed with cancer. The program will be created using Bronfenbrenner's Ecological Systems Theory and designed in collaboration with nurses, recovered adolescents, and parents. A randomized controlled design will be used. The intervention group will participate in a four-week structured program, while the control group will receive standard care. Psychosocial resilience and coping outcomes will be assessed at baseline, post-intervention, and follow-up. This research aims to offer an evidence-based, scalable model to support resilience among adolescents with cancer in clinical settings.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
36 (estimated)
First submitted
13 Nov 2025
Start date
1 Nov 2025
Primary completion date
31 Jan 2027
Lead sponsor
Eskisehir Osmangazi University
NCT number
NCT07228533

What you commit to

  • Study type: Interventional
  • Planned participants: 36
  • From 1 Nov 2025 to the primary completion date, 31 Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Receiving hematopoietic stem cell transplantation treatment,

Other illness

  • Experiencing communication difficulties (e.g., intellectual disability, visual impairment, etc.),
  • Having a psychiatric diagnosis made by a psychiatrist,

Other

  • Having developed a relapse after remission,
  • Having experienced a significant life event affecting psychological well-being within the past four weeks (e.g., death, divorce, etc.).

Who the study is looking for

  • Parents have provided informed consent after receiving information,
  • The child has given assent to participate after being informed,
  • The child is between 12 and 18 years of age,
  • The child has been diagnosed with cancer and is currently receiving inpatient treatment,
  • The child is undergoing chemotherapy and/or radiotherapy,
  • The child is able to use a computer and/or smartphone,
  • The child can understand and speak Turkish.

Age in the registry: 12 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ankara University Faculty of Medicine Cebeci Research and Practice Hospital
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.